Medication
The mission of Cleveland Clinic's Osteoporosis and Metabolic Bone Disease Center is to evaluate and treat patients with osteoporosis and other forms of diseases that affect bone. Osteoporosis is a common condition affecting both men and women. About 57 million Americans have osteoporosis and low bone mass.
Nutrition
Overview. The Center sees patients with osteoporosis, disorders of calcium metabolism, and other metabolic bone diseases including Paget's Disease, osteomalacia, osteogenesis imperfecta and others. The center has a state of the art bone densitometer, which is used to assess bone density in the hip and spine, as well as radius...
What is the Cleveland Clinic Osteoporosis and Metabolic Bone Disease Center?
Osteoporosis is a bone disorder that increases a person’s risk of fracture due to low bone mineral density (BMD), impaired bone microarchitecture/mineralization, and/or decreased bone strength.
What kind of patients does the Center for bone health treat?
We aim to treat patients at the earliest possible stage to prevent additional disease manifestations. The mission of Cleveland Clinic's Osteoporosis and Metabolic Bone Disease Center is to evaluate and treat patients with osteoporosis and other forms of diseases that affect bone. Osteoporosis is a common condition affecting both men and women.
What is osteoporosis and how is it treated?
Why choose osteoporosis and Metabolic Bone Disease Center?
What is the best doctor to go to for osteoporosis?
Rheumatologists treat patients with age-related bone diseases. They can diagnose and treat osteoporosis. Endocrinologists, who see patients with hormone-related issues, also manage the treatment of metabolic disorders such as osteoporosis. Orthopedic surgeons may fix fractures.
What is the newest treatment for osteoporosis?
Romosozumab (Evenity). This is the newest bone-building medication to treat osteoporosis. It is given as an injection every month at your doctor's office and is limited to one year of treatment.
What is the best thing to do for osteoporosis?
There are things you should do at any age to prevent weakened bones. Eating foods that are rich in calcium and vitamin D is important. So is regular weight-bearing exercise, such as weight training, walking, hiking, jogging, climbing stairs, tennis, and dancing.
Can osteoporosis be cured completely?
Osteoporosis treatment There's no cure for osteoporosis, but proper treatment can help protect and strengthen your bones. These treatments can help slow the breakdown of bone in your body, and some treatments can spur the growth of new bone.
What is the best and safest treatment for osteoporosis 2020?
Bisphosphonates are usually the first choice for osteoporosis treatment. These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel), a weekly or monthly pill.
What is the safest osteoporosis drug 2020?
The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).
What is the best and safest treatment for osteoporosis 2022?
Risedronate – Risedronate (brand names: Actonel, Atelvia) reduces the risk of both vertebral and hip fractures. Risedronate is approved for both prevention and treatment of osteoporosis. It can be taken once per day, once per week, or once per month.
What foods to avoid if you have osteoporosis?
7 Foods to Avoid When You Have OsteoporosisSalt. ... Caffeine. ... Soda. ... Red Meat. ... Alcohol. ... Wheat Bran. ... Liver and Fish Liver Oil.
Can you stop osteoporosis from getting worse?
The short answer is no, osteoporosis cannot be completely reversed and is not considered curable, but there are a number of health and lifestyle adjustments you can make to improve bone loss. Your provider may also prescribe you medications to help rebuild and slow down bone loss.
Can you increase bone density after 60?
1.Exercise Just 30 minutes of exercise each day can help strengthen bones and prevent osteoporosis. Weight-bearing exercises, such as yoga, tai chi, and even walking, help the body resist gravity and stimulate bone cells to grow. Strength-training builds muscles which also increases bone strength.
What is the life expectancy of a person with osteoporosis?
This excess risk is more pronounced in the first few years on treatment. The average life expectancy of osteoporosis patients is in excess of 15 years in women younger than 75 years and in men younger than 60 years, highlighting the importance of developing tools for long-term management.
What is the fastest way to increase bone density?
Keep reading for tips on increasing bone density naturally.Weightlifting and strength training. ... Eating more vegetables. ... Consuming calcium throughout the day. ... Eating foods rich in vitamins D and K. ... Maintaining a healthy weight. ... Avoiding a low calorie diet. ... Eating more protein. ... Eating foods rich in omega-3 fatty acids.More items...•
Which Medications Are Commonly Used For Osteoporosis Treatment?
Bisphosphonates are the most common medications prescribed for osteoporosis treatment. These include: 1. Alendronate (Fosamax) 2. Risedronate (Acto...
How Do Most Osteoporosis Medications Work?
With the exception of teriparatide, osteoporosis medications slow bone breakdown. Healthy bones continuously break down and rebuild.As you age — es...
How Do You Know If You're Taking The Right bisphosphonate?
Drugs in the bisphosphonate class are more alike than they are different. They all help maintain bone density. And, all bisphosphonates have been s...
When Might Other Osteoporosis Medications Be used?
Drugs such as denosumab, teriparatide and abaloparatide can be used by anyone with osteoporosis, but are more likely to be recommended for people w...
What Are Common Side Effects of Bisphosphonate pills?
Bisphosphonate pills aren't absorbed well in the stomach. The main side effects of bisphosphonate pills are stomach upset and heartburn. Generic fo...
Do Intravenous Bisphosphonates Have Advantages Over The Pill form?
Infused forms of bisphosphonates don't cause stomach upset. And it may be easier for some women to schedule a quarterly or yearly infusion than to...
Can Bisphosphonates Hurt Your Bones?
Long-term bisphosphonate therapy has been linked to a rare problem in which the upper thighbone cracks and may break. This injury, known as atypica...
How Long Should You Take A Bisphosphonate For Osteoporosis Treatment?
There's some uncertainty about how long to take bisphosphonates because of a lack of long-term studies. Bisphosphonates have been shown to be safe...
What Happens If You Break A Bone While Taking An Osteoporosis medication?
Osteoporosis medications lower the chance of fracture, but they don't eliminate all risk of breaking a bone. If you have a fracture while on treatm...
Can Medication Alone Successfully Treat Osteoporosis?
Don't rely entirely on medication as the only treatment for your osteoporosis. These practices also are important: 1. Exercise. Weight-bearing phys...
What is the complication of bisphosphonates and denosumab?
A very rare complication of bisphosphonates and denosumab is a break or crack in the middle of the thighbone. A second rare complication is delayed healing of the jawbone (osteonecrosis of the jaw). This can occur after an invasive dental procedure such as removing a tooth.
How long can you take teriparatide for osteoporosis?
After two years of treatment with teriparatide, another osteoporosis drug is taken to maintain the new bone growth. Abaloparatide (Tymlos) is another drug similar to parathyroid hormone. You can take it for only two years, which will be followed by another osteoporosis medication. Romosozumab (Evenity).
What is the newest bone building medication?
Romosozumab (Evenity). This is the newest bone-building medication to treat osteoporosis. It is given as an injection every month at your doctor's office. It is limited to one year of treatment, followed by other osteoporosis medications.
How often is denosumab shot?
Denosumab is delivered via a shot under the skin every six months. If you take denosumab, you might have to continue to do so indefinitely.
How to reduce the risk of osteoporosis?
Smoking increases rates of bone loss and the chance of fracture. Avoid excessive alcohol. Consuming more than two alcoholic drinks a day might decrease bone formation.
What is the best treatment for osteoporosis?
If you can't tolerate the more common treatments for osteoporosis — or if they don't work well enough — your doctor might suggest trying: Teriparatide (Forteo). This powerful drug is similar to parathyroid hormone and stimulates new bone growth. It's given by daily injection under the skin.
What are the side effects of bisphosphonates?
Examples include: Side effects include nausea, abdominal pain and heartburn-like symptoms. These are less likely to occur if the medicine is taken properly.
Can medication alone successfully treat osteoporosis?
Don't rely entirely on medication as the only treatment for your osteoporosis. These practices also are important:
What are common side effects of bisphosphonate pills?
The main side effects of bisphosphonate pills are stomach upset and heartburn. Don't lie down or bend over for 30 to 60 minutes to avoid the medicine washing back up into the esophagus. Most people who follow these tips don't have these side effects.
Do intravenous bisphosphonates have advantages over the pill form?
Intravenous forms of bisphosphonates, such as ibandronate and zoledronic acid, don't cause stomach upset. And it may be easier for some people to schedule a quarterly or yearly infusion than to remember to take a weekly or monthly pill.
Should I take a drug holiday from bisphosphonates?
So your doctor might suggest that you temporarily stop taking this type of drug. This practice is known as a drug holiday.
What is the best treatment for osteoporosis?
Bisphosphonates are usually the first choice for osteoporosis treatment. These include: 1 Alendronate (Fosamax), a weekly pill 2 Risedronate (Actonel), a weekly or monthly pill 3 Ibandronate (Boniva), a monthly pill or quarterly intravenous (IV) infusion 4 Zoledronic acid (Reclast), an annual IV infusion
What is the condition of bisphosphonates and denosumab?
A very rare complication of bisphosphonates and denosumab is a break or crack in the middle of the thighbone. This injury, known as atypical femoral fracture, can cause pain in the thigh or groin that begins subtly and may gradually worsen.
Which osteoporosis medication is usually tried first?
Which osteoporosis medications are usually tried first? Bisphosphonates are usually the first choice for osteoporosis treatment. These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel), a weekly or monthly pill. Ibandronate (Boniva), a monthly pill or quarterly intravenous (IV) infusion.
Why choose Johns Hopkins for treatment of metabolic bone, calcium and parathyroid disorders?
They have published numerous articles and textbook chapters based on their research in metabolic bone disorders and enjoy working with patients to individually design effective diet, lifestyle and treatment regimens to improve skeletal health.
What is the Johns Hopkins Metabolic Bone and Osteoporosis Center?
One of only a handful of academic centers in the United States dedicated to skeletal health, the Johns Hopkins Metabolic Bone and Osteoporosis Center is committed to providing patients and their families the care necessary to diagnose and treat disorders of bone. From osteoporosis to hyperparathyroidism to rare bone disease, we realize that every patient case is unique and deserving of thoughtful and personalized care. We hope to work with our patients, addressing their specific needs and preferences, while offering expert opinion on lifestyle interventions, nutritional factors and pharmacotherapies that can promote optimal skeletal health. There is no “textbook case” or “one size fits all” model that we employ; rather, each patient who walks through our doors brings with her/him a specific life story that must be incorporated into our evaluation and treatment plan.
What is the most common metabolic bone disorder?
Our Center is unique in that it fosters the latest in research, technology and patient care in the area of metabolic bone diseases, or disorders of bone strength, commonly caused by abnormalities of minerals (such as calcium or phosphorus), vitamin D, bone mass or bone structure. Osteoporosis is the most common metabolic bone disorder, though there are many conditions that may lead to bone deterioration, fracture or other biochemical abnormalities that we see within our walls (see Conditions We Treat). With the realization that bone is not an inanimate object, the field is ever-changing with respect to how we think about bone remodeling and quality as well as how to best target what we learn each year so that our patients are best managed (lifestyle, pharmacotherapy, other).
Which metabolic disorder is most common in humans?
Osteoporosis is the most common metabolic bone disorder, though there are many conditions that may lead to bone deterioration, fracture or other biochemical abnormalities that we see within our walls (see Conditions We Treat).
Is bone an inanimate object?
With the realization that bone is not an inanimate object, the field is ever-changing with respect to how we think about bone remodeling and quality as well as how to best target what we learn each year so that our patients are best managed (lifestyle, pharmacotherapy, other).
What is the best treatment for postmenopausal osteoporosis?
AACE/ACE provides evidence-based information for the management of postmenopausal osteoporosis (PMO). In those with no prior fragility fractures or with moderate fracture risk, alendronate, risedronate, zoledronic acid, or denosumab (Prolia, Amgen) are appropriate as first-line options, while ibandronate and raloxifene are considered alternatives. In those with prior fragility fractures or indicators of high fracture risk, denosumab, teriparatide (Forteo, Lilly), and zoledronic acid are recommended for first-line use, with alendronate and risedronate as alternatives. Indicators of high fracture risk include advanced age, frailty, glucocorticoids, very low T-scores, and increased fall risk. Teriparatide, denosumab, or zoledronic acid should be considered for those unable to use oral therapy. Raloxifene or ibandronate may be used as initial therapy for spine-specific efficacy. While sequential therapy of teriparatide followed by an antiresorptive medication is supported, combination therapy of osteoporosis medications for treatment or prevention of osteoporosis in postmenopausal women is not recommended due to limited availability of supportive data, increased cost, and potential increased side effects. 3
How many people have osteoporosis?
Approximately 10 million men and women in the U.S. have osteoporosis, 1 a metabolic bone disease characterized by low bone density and deterioration of bone architecture that increase the risk of fractures. 2 Osteoporosis-related fractures can increase pain, disability, nursing home placement, total health care costs, and mortality. 3 The diagnosis of osteoporosis is primarily determined by measuring bone mineral density (BMD) using noninvasive dual-energy x-ray absorptiometry. Osteoporosis medications include bisphosphonates, receptor activator of nuclear factor kappa-B ligand inhibitors, estrogen agonists/antagonists, parathyroid hormone analogues, and calcitonin. 3 – 6 Emerging therapies utilizing novel mechanisms include a cathepsin K inhibitor and a monoclonal antibody against sclerostin. 7, 8 While professional organizations have compiled recommendations for the management of osteoporosis in various populations, a consensus has yet to develop as to which is the gold standard; therefore, economic evaluations have been increasingly important to help guide decision-makers. A review of cost-effectiveness literature on the efficacy of oral bisphosphonates has shown alendronate and risedronate to be most cost-effective in women with low BMD without previous fractures. 9 Guidelines are inconsistent as to the place in therapy of denosumab (Prolia, Amgen). In economic analyses evaluating treatment of postmenopausal women, denosumab outperformed risedronate and ibandronate; its efficacy was comparable to generic alendronate, but it cost more. 10 With regard to older men with osteoporosis, denosumab was also found to be cost-effective when compared with bisphosphonates and teriparatide (Forteo, Lilly). 11
What is the goal of pharmacological therapy?
The goal of pharmacological therapy is to reduce the risk of fractures. 2 – 4 Medications to treat osteoporosis are categorized as either antiresorptive (i.e., bisphosphonates, estrogen agonist/ antagonists [EAAs], estrogens, calcitonin, and denosumab) or anabolic (i.e., teriparatide). Antiresorptive medications primarily decrease the rate of bone resorption while anabolic medications increase bone formation more than bone resorption. While several medications have overlapping indications, it is important to note that not all osteoporosis medications are approved by the Food and Drug Administration (FDA) to treat PMO, osteoporosis in men, and/or GIO ( Table 2 ). Per AACE/ACE guidelines, first-line treatment for most PMO patients at high risk of fracture includes alendronate, risedronate, zoledronic acid, and denosumab. For those who cannot use oral therapy and are at high risk of fracture, use of teriparatide, denosumab, or zoledronic acid is recommended. 3 This recommendation is also reflected in the ACP guidelines, and authors notably suggest treatment duration of five years for PMO, as well as first-line treatment with bisphosphonates for men with osteoporosis. 33
What causes osteoporosis in men?
Causes of secondary osteoporosis may differ between genders. For men, excessive alcohol use, glucocorticoid use, and hypogonadism are more commonly associated with osteoporosis. 22 For example, men receiving androgen-deprivation therapy (ADT) for prostate cancer are at increased risk of osteoporosis; Shahinian et al. found that 19.4% of those treated with ADT experienced a fracture compared with 12.6% of those who were not. 23 Tannenbaum et al. found that osteoporosis in 32.4% of women was attributed to secondary causes, most often hypercalciuria, malabsorption of calcium, hyperparathyroidism, vitamin D deficiency, hyperthyroidism, Cushing’s disease, and hypocalciuric hypercalcemia. Of note, disorders of calcium metabolism and hyperparathyroidism contributed to 78% of the secondary causes. 24
How much estrogen is in Duavee?
Duavee tablets contain 0.45 mg conjugated estrogens and 20 mg bazedoxifene and are dosed once daily. Its clinical role in therapy is for the prevention of osteoporosis with the additional indication of treating vasomotor symptoms, but careful consideration should be exercised because it has the same boxed warnings, precautions, and contraindications as other estrogen-containing medications. 79
When was abaloparatide approved?
Abaloparatide (Tymlos, Radius Health), the second recombinant human PTH (1–34) analogue to reach the market, received FDA approval in April 2017. 98 It is indicated for the treatment of PMO in women at high risk for fracture, defined as a history of osteoporotic fracture or multiple risk factors for fracture, and in patients who have failed or are intolerant to other available osteoporosis therapy. In a phase 3 clinical trial, abaloparatide reduced the incidence of new vertebral fracture by 86% over an 18-month period. The drug also reduced the risk for nonvertebral fracture by 43%. 99
Is raloxifene an EAA?
Raloxifene, which is characterized as an EAA, exhibits dual agonistic and antagonistic properties in estrogenic pathways. Raloxifene acts as an estrogenic agonist on the bone by decreasing bone resorption and bone turnover, thus increasing BMD. It also has estrogen antagonistic activity on breast and uterine tissue. The AACE/ACE recommends raloxifene as an appropriate first-line therapy for patients requiring reduced risk of spine fracture only. Due to its selective antagonistic effects on breast tissue, raloxifene may be considered in women with an increased risk of vertebral fractures who may be at risk for developing breast cancer. 76 Raloxifene can also be used as a weaker antiresorptive therapy for higher-risk patients during a bisphosphonate holiday. 3 The MORE study was a multicenter, randomized, blinded, placebo-controlled trial of 7,705 women diagnosed with osteoporosis who had been post-menopausal for at least two years. The results demonstrated a four-year cumulative relative risk of 0.7 (95% CI, 0.5–0.8) for new vertebral fractures and relative risk of 0.9 (95% CI, 0.8–1.1) that was not significant for nonvertebral fractures. 77 A substudy of the MORE trial by Ettinger et al. reported an increase in BMD of 2.1% and 2.6% at the femoral neck and spine, respectively, in women who received raloxifene 60 mg per day compared with women who received placebo. The relative risk of 0.7 (95% CI, 0.5–0.8) was significant for vertebral fractures and the relative risk of 0.9 (95% CI, 0.8–1.1) was not significant for nonvertebral fractures in women receiving raloxifene 60 mg per day. 78
What is the bone densitometer used for?
The center has a state of the art bone densitometer, which is used to assess bone density in the hip and spine, as well as radius and total body if clinically indicated. This technique allows the physicians to evaluate the degree of bone loss, to diagnose osteoporosis and the risk for future fracture.
What is the Cleveland Clinic's osteoporosis and metabolic bone disease center?
Cleveland Clinic's Osteoporosis and Metabolic Bone Disease Center is devoted to the evaluation and treatment of patients with osteoporosis and other forms of diseases that affect bone.
What is the Cleveland Clinic's mission?
The mission of Cleveland Clinic's Osteoporosis and Metabolic Bone Disease Center is to evaluate and treat patients with osteoporosis and other forms of diseases that affect bone. Osteoporosis is a common condition affecting both men and women. About 57 million Americans have osteoporosis and low bone mass. About 34 million are at risk ...
Why is osteoporosis called a silent disease?
Osteoporosis is often called a silent disease because bone loss occurs without symptoms. The first symptom is often a fracture. By that time, a woman has often lost 30% or more of her bone mass. If evaluated at an early stage, patients can initiate prevention and treatment prior to the clinical manifestations of this silent disease.
How many women break bones?
Estimates suggest that about half of all women older than 50, and up to one in four men, will break a bone because of osteoporosis. Since a woman has a greater than 50% chance of having a fracture, this is an important disease to evaluate and treat as early as possible. Osteoporosis is often called a silent disease because bone loss occurs without ...
What is a Cleveland Clinic virtual second opinion?
Following a comprehensive evaluation of medical records and labs, you’ll receive an educational second opinion from an expert in their medical condition covering diagnosis, treatment options or alternatives as well as recommendations regarding future therapeutic considerations. You’ll also have the unique opportunity to speak with the physician expert directly to address questions or concerns. Learn more.
Can osteoporosis be reversed?
Your bones gain mass from infancy through your early 20s. Then, as you age, you begin to lose bone mineral density. This occurs in everyone, although the porousness of your bones and the rate at which the density loss occurs vary from person to person.
What is the most common type of osteoporosis medication?
The most common class of osteoporosis drugs is bisphosphonates, which are antiresorptive chemicals designed to reduce bone loss. Other, less common types of osteoporosis medication include the family of drugs called denosumab, teriparatide, and abaloparatide.
How likely is osteoporosis to develop as a mature woman?
The likelihood of developing osteoporosis as a mature woman depends largely on how much bone mass you cultivated as a young woman.
Why does osteoporosis happen?
Essentially, osteoporosis is caused by your body failing to produce new bone tissue fast enough to replace the older bone cells as they break down .
How to increase bone density?
Increasing your bone density through healthy lifestyle choices can reduce your risk of osteoporosis. Eating the right foods, especially those rich in calcium and the correct amounts of vitamin D, help create stronger, denser bones. If you have dietary restrictions such as a dairy intolerance that make it hard to get enough calcium, consider an over-the-counter supplement. Both men and women under 50 years old need 1,000 milligrams of calcium per day. Women over 50 and men over 70 need 1,200 milligrams per day. Use caution when supplementing your diet with calcium, however, as more than 2,000 milligrams per day can lead to kidney stones and heart disease.
Why is osteoporosis a progressive disease?
Osteoporosis results from too little calcium, leading to weakened bones. It’s a progressive disease and affects about 1 in 3 women aged 50 years and over.
What is the most common treatment for osteoporosis?
The most common class of osteoporosis drugs is bisphosphonates, which are antiresorptive chemicals designed to reduce bone loss. Essentially, bisphosphonate therapy slows the rate at which bone cells break down and speeds up the regeneration of new cells.
What is the best treatment for osteoporosis?
Long-term use of bisphosphonates increases the risk of fractures so they should not be used beyond 3-5 years. Prolia, with the generic name Denosumab, is a type of monoclonal antibody, which stops the natural breakdown of bones. Prolia is injected two times per year. It should only be used if other treatment methods have failed or by post-menopausal women who have severe osteoporosis. The National Women’s Health Network suggests women try other FDA-approved osteoporosis medications prior to trying Prolia . This drug has a long list of side effects and it’s also important to note that long-term risks are unknown. The FDA Medication Guide lists the potential health problems, which include serious infections, thighbone fractures, and jaw bone problems. It is unclear if the benefits outweigh the risks.
What is the disease that causes bones to become weak and fragile?
Osteoporosis is a disease that causes your bones to lose tissue and become weak and fragile, potentially leading to bone fractures. Prevention and treatment methods can help inhibit fractures and decrease the severity of osteoporosis. Is Prolia a Safe Treatment Option for Osteoporosis ?
How to prevent osteoporosis without medication?
Answer. There are many ways to prevent and treat osteoporosis from worsening without taking medications. One way is through your diet. It is important to get adequate amounts of calcium and vitamin D because they help build and preserve your bone strength.
How often is Prolia injected?
Prolia, with the generic name Denosumab, is a type of monoclonal antibody, which stops the natural breakdown of bones. Prolia is injected two times per year. It should only be used if other treatment methods have failed or by post-menopausal women who have severe osteoporosis. The National Women’s Health Network suggests women try other ...
What are some exercises that help with bone density?
Examples of weight-bearing exercises include hiking, jogging, and stair climbing. Examples of muscle-strengthening exercises include weight lifting and weight machines ...
What are some examples of muscle strengthening exercises?
Examples of muscle-strengthening exercises include weight lifting and weight machines but even using your own body weight can work. It’s also important to avoid smoking and excessive alcohol consumption to preserve bone health. Drug treatments are available if alternative prevention and treatment methods are not working.
Can you overdiagnose osteoporosis?
You should consult with your healthcare provider to discuss what osteoporosis treatment method is right for you, whether that includes a medication or non-drug alternative.
Diagnosis
Treatment
Clinical Trials
Lifestyle and Home Remedies
Specialist to consult
Preparing For Your Appointment